Voloridge Investment Management
ALDR

Voloridge Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Voloridge Investment Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-35,500
Closed -$670K – 1475
2019
Q3 		$670K Buy
+35,500
New +$406K 0.01% 728

Voloridge Investment Management's ALDR Position: Q4 2019 in Review

Voloridge Investment Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 35,500 shares — an estimated $670K sold.

Voloridge Investment Management first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $670K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Voloridge Investment Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Voloridge Investment Management sold 35,500 Alder Biopharmaceuticals shares in Q4 2019, an estimated $670K.
  • Voloridge Investment Management first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Voloridge Investment Management's Alder Biopharmaceuticals position peaked at $670K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Voloridge Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.